New class of Antibiotics disrupts protein synthesis

Antimicrobial Drugs : Odilorhabdins


Odilorhabdins, or ODLs, a new class of antibiotics which disrupts protein synthesis are produced by symbiotic bacteria Xenorhabdus Nematophilia, found in soil-dwelling nematode worms that colonize insects for food. The bacteria Xenorhabdus Nematophilia actually helps to kill the insect and, importantly, secrete the antibiotic to keep competating the other bacteria away. Till now, these nematode-associated bacteria and the antibiotics they make have been largely understudied. To identify the antibiotic property present in the xenorhabdus bacteria, researchers screened 80 cultured strains of the bacteria & isolated the active compounds showing properties of antibiotics, studied their chemical structures and engineered more potent derivatives. ODLs mainly act on the ribosome, which is the molecular machine of individual cells that makes the proteins it needs to function of bacterial cells.
Like many clinically useful antibiotics, ODLs work by targeting the ribosome, but ODLs are unique because they bind to a place on the ribosome that has never been used by other known antibiotics. The ODLs when binds to the ribosome, the antibiotic disrupts its ability to interpret and translate genetic code. When ODLs are introduced to the bacterial cells, they impact the reading ability of the ribosome and cause the ribosome to make mistakes when it creates new proteins. This miscoding corrupts the cell with flawed proteins and causes the bacterial cell death. Many antibiotics can slow bacterial growth, but the antibiotics that actually kill bacteria, called bactericidal antibiotics, are rare. The bactericidal mechanism of ODLs and the fact that they bind to a site on the ribosome not exploited by any known antibiotic are very strong indicators that it has the potential to treat infections that are unresponsive to other antibiotics.
Now-a-days WHO is also focusing on antibiotic resistant, which is one of the gigantic threats to global health today and a significant contributor to longer hospital stays, higher medical costs and increased mortality? The researchers, academics & pharma industries have been collaborated with each other , which is needed to combat the growing and global threat of antibiotic resistance. Currently, pharma professionals, microbiologists & academia are working together for this.

Comments

Post a Comment

Popular posts from this blog

Petting zoos transmit Virulent drug-resistant bacteria to visitors

Image
Human infectious diseases :  Petting zoos transmit Virulent drug-resistant bacteria to visitors Petting zoos are a popular attraction around the world, allowing direct and indirect exposure of both children and adults to a diverse range of animal species. They are different from regular zoos because rather than visitors just looking at the animals, petting zoos are interactive with children visiting, holding and petting the animals. Extended spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacteriaceae (AmpC-E), which are resistant to a number of commonly used antibiotics, have become a matter of great concern in both human and veterinary medicine, so understanding the likelihood of them colonizing the animals is critical to evaluating the risk that may be posed to visitors. The researchers did a survey across randomly chosen petting zoos geographically distributed throughout the world, taking samples of faecal matter as well as from the body surface (skin, fur, or feat
Read more

How to block new antibiotic resistance gene???

Image
A new antimicrobial-resistance gene, VCC-1, a ß-lactamase gene, has been discovered in benign close relatives of virulent Vibrio cholerae, which causes cholera. Now, researchers have found a way to block the VCC-1 enzyme, which disables that resistance gene. The research is published in the journal Antimicrobial agents & chemotherapy . VCC-1 was first found in Canada, by investigators from the Public Health Agency of Canada, on frozen shrimp that had been imported from India, and sold in a Canadian grocery store. A handful of other ß-lactamase resistance genes have also emerged from India. ß-lactamase genes code for enzymes that can break down ß-lactams, which are a critically important class of antimicrobials . The researchers identified the gene in a non-toxigenic strain of Vibrio cholerae. Since then, VCC-1 has also been found in non-toxigenic V. cholerae off of the German coastline. The danger is that it's a short jump for a gene from non-toxigenic V. cholerae to
Read more

Antimicrobial Resistance:Searching for clues to fight antibiotic resistance

Image
To conflict the rise of drug-resistant bacteria , researchers are developing how one superbug bacteria adapts to fight with an antibiotic of last resort, hoping to find clues that can lengthen the drug's effectiveness. Researchers at Rice University and the University Of Texas Health Science Centre at Houston ran experiments to track the biochemical changes that vancomycin-resistant Enterococci (VRE) underwent as they adapted to fight another antibiotic, daptomycin. "We need to get to a platform where we can anticipate how these pathogens will become resistant to antibiotics so we can stay one step ahead of them," said Rice biochemist Youssef Shampoo, co-author of a study in the journal Antimicrobial Agents and Chemotherapy that found VRE can develop resistance to daptomycin in more than one way. The stakes are high. In 2014, the World Health Organization reported that antibiotic-resistant infections were on pace to kill 10 million people per year worl
Read more